Position in ABBV
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$2,337,231
+$317,185 QoQ
Shares Held
9,288
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.64%
of 13F equity value
Holder Rank
#1,844
of 4,150 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 5%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FIRST FINANCIAL CORP /IN/ holds $10,663,305 across 12 Drug Manufacturers - General names. ABBV ranks #2 (21.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,212 | $5,051,998 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
9,288 | $2,337,231 | |
| 3 | MRK |
Merck & Co., Inc.
|
11,730 | $1,507,305 | |
| 4 | JNJ |
Johnson & Johnson
|
2,095 | $532,067 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
8,635 | $497,548 | |
| 6 | NVO |
Novo Nordisk A S
|
6,470 | $310,171 | |
| 7 | PFE |
Pfizer Inc
|
10,210 | $245,856 | |
| 8 | NVS |
Novartis AG
|
599 | $93,875 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,337,231 | 9,288 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $2,020,046 | 9,288 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $2,139,351 | 9,363 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $2,179,485 | 9,413 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $1,763,760 | 9,502 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $1,997,144 | 9,532 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $1,783,930 | 10,039 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $2,007,976 | 10,168 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $1,766,312 | 10,298 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $2,017,303 | 11,078 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $2,519,036 | 16,255 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $2,514,194 | 16,867 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $1,298,796 | 9,640 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $1,567,244 | 9,834 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $1,616,099 | 10,000 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $1,344,783 | 10,020 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $1,545,231 | 10,089 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $1,641,849 | 10,128 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $1,389,609 | 10,263 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $1,101,567 | 10,212 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $1,156,587 | 10,268 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $1,064,992 | 9,841 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $1,046,212 | 9,764 | Shares | Sole | 2021-01-15 | |
| 2020-09-30 | $850,411 | 9,709 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $956,174 | 9,739 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $752,375 | 9,875 | Shares | Sole | 2020-04-15 | |
| No filing history on record for this holder in this stock. | ||||||